These molecules are capable of decreasing the expression of GLUT-4 by downregulation of PPAR-γ signaling and alteration of PI3K/Akt activation in skeletal muscle cells and adipocytes, leading to insulin resistance [52,59,60]. The gene discussed is SLC2A4; the disease is Insulin resistance.